Surface-engineered graphene-based nanomaterials for drug delivery

Journal of Biomedical Nanotechnology

Volumn 10, Issue 9, 2014, Pages 2086-2106

  Dong, Haiqing ^a   Dong, Chunyan ^a   Ren, Tianbin ^a   Li, Yongyong ^a   Shi, Donglu ^a,b  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b 705 Engineering Research Center   (United States)

Author keywords

Biomedical applications; Biosafety; Drug delivery; Gene delivery; Graphene based nanomaterial; Photothermal therapy; Theranostics

Indexed keywords

BIOHAZARDS; DRUG DELIVERY; GENE TRANSFER; INDUSTRIAL RESEARCH; INTERFACES (MATERIALS); MEDICAL APPLICATIONS; MEDICAL IMAGING; NANOSTRUCTURED MATERIALS; PHOTOSENSITIZERS; STEM CELLS;

BIOMEDICAL APPLICATIONS; BIOSAFETY; GENE DELIVERY; NANOMATERIAL; PHOTOTHERMAL THERAPY; THERANOSTICS;

GRAPHENE;

AMANTADINE; CAMPTOTHECIN; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GRAPHENE; GRAPHENE OXIDE; HYPOCRELLIN A; HYPOCRELLIN B; LEVOFLOXACIN; METHOTREXATE; NANOMATERIAL; PHTHALOCYANINE ZINC; PLASMID DNA; POLOXAMER; QUANTUM DOT; SMALL INTERFERING RNA; TAMOXIFEN CITRATE; GRAPHITE;

ANTINEOPLASTIC ACTIVITY; BIOMEDICAL ENGINEERING; BIOSAFETY; DRUG DELIVERY SYSTEM; DRUG TARGETING; GENE TARGETING; HUMAN; NONHUMAN; PHOTODYNAMIC THERAPY; REVIEW; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; CHEMISTRY; NANOTECHNOLOGY; PROCEDURES; SURFACE PROPERTY;

ANIMALS; DRUG DELIVERY SYSTEMS; GRAPHITE; HUMANS; NANOSTRUCTURES; NANOTECHNOLOGY; SURFACE PROPERTIES;

EID: 84904870986     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2014.1989     Document Type: Review

References (209)

1. H. Y. Mao, S. Laurent, W. Chen, O. Akhavan, M. Imani, A. A. Ashkarran, and M. Mahmoudi, Graphene: Promises, facts, opportunities, and challenges in nanomedicine. Chem. Rev. 113, 3407 (2013).
2. A. K. Geim and K. S. Novoselov, The rise of graphene. Nat. Mater. 6, 183 (2007).
3. K. S. Novoselov, A. K. Geim, S. V. Morozov, D. Jiang, Y. Zhang, S. V. Dubonos, I. V. Grigorieva, and A. A. Firsov, Electric field effect in atomically thin carbon films. Science 306, 666 (2004).
4. F. Schwierz, ELECTRONICS industry-compatible graphene transistors. Nature 472, 41 (2011).
5. C. Chung, Y. K. Kim, D. Shin, S. R. Ryoo, B. H. Hong, and D. H. Min, Biomedical applications of graphene and graphene oxide. Acc. Chem. Res. 46, 2211 (2013).
6. X. M. Wang and W. H. Zhang, Application of graphene derivatives in cancer therapy a review. New Carbon Mater. 28, 321 (2013).
7. K. F. Mak, M. Y. Sfeir, J. A. Misewich, and T. F. Heinz, The evolution of electronic structure in few-layer graphene revealed by optical spectroscopy. Proc. Natl. Acad. Sci. USA 107, 14999 (2010).
8. N. Li, Q. Zhang, S. Gao, Q. Song, R. Huang, L. Wang, L. W. Liu, J. W. Dai, M. L. Tang, and G. S. Cheng, Three-dimensional graphene foam as a biocompatible and conductive scaffold for neural stem cells. Sci. Rep.-UK 3, 1604 (2013).
9. C. Heo, J. Yoo, S. Lee, A. Jo, S. Jung, H. Yoo, Y. H. Lee, and M. Suh, The control of neural cell-to-cell interactions through non-contact electrical field stimulation using graphene electrodes. Biomaterials 32, 19 (2011).
10. M. Liu, H. M. Zhao, S. Chen, H. T. Yu, Y. B. Zhang, and X. Quan, A "turn-on" fluorescent copper biosensor based on DNA cleavage-dependent graphene-quenched DNAzyme. Biosens. Bioelectron. 26, 4111 (2011).
11. Z. Yang, R. G. Gao, N. T. Hu, J. Chai, Y. W. Cheng, L. Y. Zhang, H. Wei, E. S. W. Kong, and Y. F. Zhang, The prospective two-dimensional graphene nanosheets: Preparation, functionalization, and applications. Nano-Micro Lett. 4, 1 (2012).
12. Y. Zhang, T. R. Nayak, H. Hong, and W. Cai, Graphene: A versatile nanoplatform for biomedical applications. Nanoscale 4, 3833 (2012).
13. S. Naahidi, M. Jafari, F. Edalat, K. Raymond, A. Khademhosseini, and P. Chen, Biocompatibility of engineered nanoparticles for drug delivery. J. Control Release 166, 182 (2013).
14. K. Yang, L. Z. Feng, X. Z. Shi, and Z. Liu, Nano-graphene in biomedicine: Theranostic applications. Chem. Soc. Rev. 42, 530 (2013).
15. L. Y. Feng, L. Wu, and X. G. Qu, New horizons for diagnostics and therapeutic applications of graphene and graphene oxide. Adv. Mater. 25, 168 (2013).
16. H. Shen, L. M. Zhang, M. Liu, and Z. J. Zhang, Biomedical applications of graphene. Theranostics 2, 283 (2012).
17. A. Bianco, Graphene: Safe or toxic? The two faces of the medal. Angew. Chem. Int. Edit. 52, 4986 (2013).
18. D. Bitounis, H. Ali-Boucetta, B. H. Hong, D. H. Min, and K. Kostarelos, Prospects and challenges of graphene in biomedical applications. Adv. Mater. 25, 2258 (2013).
19. L. Feng and Z. Liu, Graphene in biomedicine: Opportunities and challenges. Nanomed. 6, 317 (2011).
20. Y. Yang, A. M. Asiri, Z. Tang, D. Du, and Y. Lin, Graphene based materials for biomedical applications. Mater. Today 16, 365 (2013).
21. J. C. Meyer, A. K. Geim, M. I. Katsnelson, K. S. Novoselov, T. J. Booth, and S. Roth, The structure of suspended graphene sheets. Nature 446, 60 (2007).
22. S. Ryu and B.-S. Kim, Culture of neural cells and stem cells on graphene. Tissue Eng. Regen. Med. 10, 39 (2013).
23. W. Wang, F. Watari, M. Omori, S. Liao, Y. H. Zhu, A. Yokoyama, M. Uo, H. Kimura, and A. Ohkubo, Mechanical properties and biological behavior of carbon nanotube/polycarbosilane composites for implant materials. J. Biomed. Mater. Res. B 82B, 223 (2007).
24. D. Sahni, A. Jea, J. A. Mata, D. C. Marcano, A. Sivaganesan, J. M. Berlin, C. E. Tatsui, Z. Sun, T. G. Luerssen, S. Meng, T. A. Kent, and J. M. Tour, Biocompatibility of pristine graphene for neuronal interface Laboratory investigation. J. Neurosurg.-Pediatr. 11, 575 (2013).
25. Z. M. Markovic, B. Z. Ristic, K. M. Arsikin, D. G. Klisic, L. M. Harhaji-Trajkovic, B. M. Todorovic-Markovic, D. P. Kepic, T. K. Kravic-Stevovic, S. P. Jovanovic, M. M. Milenkovic, D. D. Milivojevic, V. Z. Bumbasirevic, M. D. Dramicanin, and V. S. Trajkovic, Graphene quantum dots as autophagy-inducing photodynamic agents. Biomaterials 33, 7084 (2012).
26. H. J. Sun, L. Wu, N. Gao, J. S. Ren, and X. G. Qu, Improvement of photoluminescence of graphene quantum dots with a biocompatible photochemical reduction pathway and its bioimaging application. ACS Appl. Mater. Inter. 5, 1174 (2013).
27. J. H. Shen, Y. H. Zhu, X. L. Yang, and C. Z. Li, Graphene quantum dots: Emergent nanolights for bioimaging, sensors, catalysis and photovoltaic devices. Chem. Commun. 48, 3686 (2012).
28. S. N. Baker and G. A. Baker, Luminescent carbon nanodots: Emergent nanolights. Angew. Chem. Int. Edit. 49, 6726 (2010).
29. X. J. Zhou, S. W. Guo, and J. Y. Zhang, Solution-processable graphene quantum dots. ChemPhysChem 14, 2627 (2013).
30. X. T. Zheng, A. Than, A. Ananthanaraya, D. H. Kim, and P. Chen, Graphene quantum dots as universal fluorophores and their use in revealing regulated trafficking of insulin receptors in adipocytes. ACS Nano 7, 6278 (2013).
31. C. Y. Wu, C. Wang, T. Han, X. J. Zhou, S. W. Guo, and J. Y. Zhang, Insight into the cellular internalization and cytotoxicity of graphene quantum dots. Adv. Healthc. Mater. 2, 1613 (2013).
32. H. Q. Dong, Y. Y. Li, J. H. Yu, Y. Y. Song, X. J. Cai, J. Q. Liu, J. M. Zhang, R. C. Ewing, and D. L. Shi, A versatile multicomponent assembly via-cyclodextrin hostguest chemistry on graphene for biomedical applications. Small 9, 446 (2013).
33. H. Y. Wen, C. Y. Dong, H. Q. Dong, A. J. Shen, W. J. Xia, X. J. Cai, Y. Y. Song, X. Q. Li, Y. Y. Li, and D. L. Shi, Engineered redox-responsive PEG detachment mechanism in pegylated nanographene oxide for intracellular drug delivery. Small 8, 760 (2012).
34. A. J. Shen, D. L. Li, X. J. Cai, C. Y. Dong, H. Q. Dong, H. Y. Wen, G. H. Dai, P. J. Wang, and Y. Y. Li, Multifunctional nanocomposite based on graphene oxide for in vitro hepatocarcinoma diagnosis and treatment. J. Biomed. Mater. Res. A 100A, 2499 (2012).
35. T. B. Ren, L. Li, X. J. Cai, H. Q. Dong, S. M. Liu, and Y. Y. Li, Engineered polyethylenimine/graphene oxide nanocomposite for nuclear localized gene delivery. Polym. Chem.-UK 3, 2561 (2012).
36. H. Q. Hu, J. H. Yu, Y. Y. Li, J. Zhao, and H. Q. Dong, Engineering of a novel pluronic F127/graphene nanohybrid for pH responsive drug delivery. J. Biomed. Mater. Res. A 100A, 141 (2012).
37. H. Q. Dong, Z. L. Zhao, H. Y. Wen, Y. Y. Li, F. F. Guo, A. J. Shen, P. Frank, C. Lin, and D. L. Shi, Poly(ethylene glycol) conjugated nano-graphene oxide for photodynamic therapy. Sci. China Chem. 53, 2265 (2010).
38. X. M. Sun, Z. Liu, K. Welsher, J. T. Robinson, A. Goodwin, S. Zaric, and H. J. Dai, Nano-graphene oxide for cellular imaging and drug delivery. Nano Res. 1, 203 (2008).
39. J. Q. Liu, W. R. Yang, L. Tao, D. Li, C. Boyer, and T. P. Davis, Thermosensitive graphene nanocomposites formed using pyrene-terminal polymers made by RAFT polymerization. J. Polym. Sci. Pol. Chem. 48, 425 (2010).
40. K. Yang, L. Feng, H. Hong, W. Cai, and Z. Liu, Preparation and functionalization of graphene nanocomposites for biomedical applications. Nat. Protoc. 8, 2392 (2013).
41. M. Quintana, A. Montellano, A. E. D. Castillo, G. Van Tendeloo, C. Bittencourt, and M. Prato, Selective organic functionalization of graphene bulk or graphene edges. Chem. Commun. 47, 9330 (2011).
42. H. Hong, Y. Zhang, J. W. Engle, T. R. Nayak, C. P. Theuer, R. J. Nickles, T. E. Barnhart, and W. Cai, In vivo targeting and positron emission tomography imaging of tumor vasculature with Ga-66-labeled nano-graphene. Biomaterials 33, 4147 (2012).
43. J. Zhang, L. Feng, X. Tan, X. Shi, L. Xu, Z. Liu, and R. Peng, Dual-polymer-functionalized nanoscale graphene oxide as a highly effective gene transfection agent for insect cells with cell-type-dependent cellular uptake mechanisms. Part. Part. Syst. Char. 30, 794 (2013).
44. H. Kim, D. Lee, J. Kim, T.-I. Kim, and W. J. Kim, Photothermally triggered cytosolic drug delivery via endosome disruption using a functionalized reduced graphene oxide. ACS Nano 7, 6735 (2013).
45. Z. Fan, J. Wang, Z. Wang, Z. Li, Y. Qiu, H. Wang, Y. Xu, L. Niu, P. Gong, and S. Yang, Casein phosphopeptide-biofunctionalized graphene biocomposite for hydroxyapatite biomimetic mineralization. J. Phys. Chem. C 117, 10375 (2013).
46. X. F. Cao, F. L. Feng, Y. S. Wang, X. Y. Yang, H. Q. Duan, and Y. S. Chen, Folic acid-conjugated graphene oxide as a transporter of chemotherapeutic drug and siRNA for reversal of cancer drug resistance. J. Nanopart. Res. 15, 1965 (2013).
47. J. F. Shen, M. Shi, B. Yan, H. W. Ma, N. Li, Y. Z. Hu, and M. X. Ye, Covalent attaching protein to graphene oxide via diimide-activated amidation. Colloid. Surface. B 81, 434 (2010).
48. J. H. Jung, D. S. Cheon, F. Liu, K. B. Lee, and T. S. Seo, A graphene oxide based immuno-biosensor for pathogen detection. Angew. Chem. Int. Edit. 49, 5708 (2010).
49. K. Yang, J. Wan, S. Zhang, B. Tian, Y. Zhang, and Z. Liu, The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power. Biomaterials 33, 2206 (2012).
50. M. Nurunnabi, Z. Khatun, M. Nafiujjaman, D.-G. Lee, and Y.-K. Lee, Surface coating of graphene quantum dots using mussel-inspired polydopamine for biomedical optical imaging. ACS Appl. Mater. Inter. 5, 8246 (2013).
51. C. Cheng, S. Nie, S. Li, H. Peng, H. Yang, L. Ma, S. Sun, and C. Zhao, Biopolymer functionalized reduced graphene oxide with enhanced biocompatibility via mussel inspired coatings/anchors. J. Mater. Chem. B 1, 265 (2013).
52. R. K. Layek and A. K. Nandi, A review on synthesis and properties of polymer functionalized graphene. Polymer 54, 5087 (2013).
53. Y. Wang, Z. Li, J. Wang, J. Li, and Y. Lin, Graphene and graphene oxide: Biofunctionalization and applications in biotechnology. Trends Biotechnol. 29, 205 (2011).
54. S. Gurunathan, J. W. Han, V. Eppakayala, A. A. Dayem, D.-N. Kwon, and J.-H. Kim, Biocompatibility effects of biologically synthesized graphene in primary mouse embryonic fibroblast cells. Nanoscale Res. Lett. 8 (2013).
55. S. Thakur and N. Karak, Green reduction of graphene oxide by aqueous phytoextracts. Carbon 50, 5331 (2012).
56. C. Z. Zhu, S. J. Guo, Y. X. Fang, and S. J. Dong, Reducing sugar: New functional molecules for the green synthesis of graphene nanosheets. ACS Nano 4, 2429 (2010).
57. R. Justin and B. Chen, Body temperature reduction of graphene oxide through chitosan functionalisation and its application in drug delivery. Mater. Sci. Eng. C 34, 50 (2014).
58. Y. Q. Guo, X. Y. Sun, Y. Liu, W. Wang, H. X. Qiu, and J. P. Gao, One pot preparation of reduced graphene oxide (RGO) or Au (Ag) nanoparticle-RGO hybrids using chitosan as a reducing and stabilizing agent and their use in methanol electrooxidation. Carbon 50, 2513 (2012).
59. J. An, Y. Gou, C. Yang, F. Hu, and C. Wang, Synthesis of a biocompatible gelatin functionalized graphene nanosheets and its application for drug delivery. Mat. Sci. Eng. C-Mater. 33, 2827 (2013).
60. S. Kanakia, J. D. Toussaint, S. M. Chowdhury, G. Lalwani, T. Tembulkar, T. Button, K. R. Shroyer, W. Moore, and B. Sitharaman, Physicochemical characterization of a novel graphene-based magnetic resonance imaging contrast agent. Int. J. Nanomed. 8, 2821 (2013).
61. S. M. Chowdhury, S. Kanakia, J. D. Toussaint, M. D. Frame, A. M. Dewar, K. R. Shroyer, W. Moore, and B. Sitharaman, In vitro hematological and in vivo vasoactivity assessment of dextran functionalized graphene. Sci. Rep.-UK 3, 2584 (2013).
62. Y. K. Kim, M. H. Kim, and D. H. Min, Biocompatible reduced graphene oxide prepared by using dextran as a multifunctional reducing agent. Chem. Commun. 47, 3195 (2011).
63. H. Peng, L. Meng, L. Niu, and Q. Lu, Simultaneous reduction and surface functionalization of graphene oxide by natural cellulose with the assistance of the ionic liquid. J. Phys. Chem. C 116, 16294 (2012).
64. J. B. Liu, S. H. Fu, B. Yuan, Y. L. Li, and Z. X. Deng, Toward a universal "adhesive nanosheet" for the assembly of multiple nanoparticles based on a protein-induced reduction/decoration of graphene oxide. J. Am. Chem. Soc. 132, 7279 (2010).
65. H. Maeda, The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting. Adv. Enzyme Regul. 41, 189 (2001).
66. R. Duncan and Y. N. Sat, Tumour targeting by enhanced permeability and retention (EPR) effect. Ann. Oncol. 9, 39 (1998).
67. F. Danhier, O. Feron, and V. Preat, To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J. Control Release 148, 135 (2010).
68. Y. Matsumura and H. Maeda, A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46, 6387 (1986).
69. K. Park, Questions on the role of the EPR effect in tumor targeting. J. Control Release 172, 391 (2013).
70. H. Maeda, H. Nakamura, and J. Fang, The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv. Drug Deliver. Rev. 65, 71 (2013).
71. H. Maeda, The link between infection and cancer: Tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect. Cancer Sci. 104, 779 (2013).
72. R. Duncan, Y. N. Sat-Klopsch, A. M. Burger, M. C. Bibby, H. H. Fiebig, and E. A. Sausville, Validation of tumour models for use in anticancer nanomedicine evaluation: The EPR effect and cathepsin B-mediated drug release rate. Cancer Chemother. Pharmacol. 72, 417 (2013).
73. H. Maeda, Macromolecular therapeutics in cancer treatment: The EPR effect and beyond. J. Control Release 164, 138 (2012).
74. K. Yang, J. M. Wan, S. Zhang, B. Tian, Y. J. Zhang, and Z. Liu, The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power. Biomaterials 33, 2206 (2012).
75. J. H. Park, S. Lee, J. H. Kim, K. Park, K. Kim, and I. C. Kwon, Polymeric nanomedicine for cancer therapy. Prog. Polym. Sci. 33, 113 (2008).
76. F. Marcucci and F. Lefoulon, Active targeting with particulate drug carriers in tumor therapy: Fundamentals and recent progress. Drug Discov. Today 9, 219 (2004).
77. L. Fiandra, S. Mazzucchelli, C. De Palma, M. Colombo, R. Allevi, S. Sommaruga, E. Clementi, M. Bellini, D. Prosperi, and F. Corsi, Assessing the in vivo targeting efficiency of multifunctional nanoconstructs bearing antibody-derived ligands. ACS Nano 7, 6092 (2013).
78. S. Jager, A. Jahnke, S. Adebar, F. N. Vogtle, E. Delima-Hahn, D. Pfeifer, T. Berg, M. Lubbert, and M. Trepel, Peptide ligands targeting integrins on acute myeloid leukemia cells. Onkologie 31, 100 (2008).
79. O. C. Farokhzad, J. Cheng, B. Tepiy, A. Khademhosseini, S. Jon, E. Levy-Nissenbaum, and R. Langer, Cancer nanotechnology: Drug encapsulated nanoparticle-aptamer bioconjugates for targeted delivery to prostate cancer cells. EJC Suppl. 3, 229 (2005).
80. O. J. Kwon, E. Kang, J. W. Choi, S. W. Kim, and C. O. Yun, Therapeutic targeting of chitosan-PEG-folate-complexed oncolytic adenovirus for active and systemic cancer gene therapy. J. Control Release 169, 257 (2013).
81. G. Liu, H. Shen, J. Mao, L. Zhang, Z. Jiang, T. Sun, Q. Lan, and Z. Zhang, Transferrin modified graphene oxide for glioma-targeted drug delivery: In vitro and in vivo evaluations. ACS Appl. Mater. Inter. 5, 6909 (2013).
82. N. Abdullah Al, J.-E. Lee, I. In, H. Lee, K. D. Lee, J. H. Jeong, and S. Y. Park, Target delivery and cell imaging using hyaluronic Acid-functionalized graphene quantum dots. Mol. Pharm. 10, 3736 (2013).
83. C. Chung, Y.-K. Kim, D. Shin, S.-R. Ryoo, B. H. Hong, and D.-H. Min, Biomedical applications of graphene and graphene oxide. Acc. Chem. Res. 46, 2211 (2013).
84. S. Makharza, G. Cirillo, A. Bachmatiuk, I. Ibrahim, N. Ioannides, B. Trzebicka, S. Hampel, and M. H. Rummeli, Graphene oxidebased drug delivery vehicles: Functionalization, characterization, and cytotoxicity evaluation. J. Nanopart. Res. 15, 2099 (2013).
85. J. Q. Liu, L. Cui, and D. Losic, Graphene and graphene oxide as new nanocarriers for drug delivery applications. Acta Biomater. 9, 9243 (2013).
86. X. Y. Yang, X. Y. Zhang, Z. F. Liu, Y. F. Ma, Y. Huang, and Y. Chen, High-efficiency loading and controlled release of doxorubicin hydrochloride on graphene oxide. J. Phys. Chem. C 112, 17554 (2008).
87. Z. Liu, J. T. Robinson, X. M. Sun, and H. J. Dai, PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J. Am. Chem. Soc. 130, 10876 (2008).
88. K. R. Hande, Clinical applications of anticancer drugs targeted to topoisomerase II. BBA-Gene Struc. Expr. 1400, 173 (1998).
89. S. Patel, A. U. Sprung, B. A. Keller, V. J. Heaton, and L. M. Fisher, Identification of yeast DNA topoisomerase II mutants resistant to the antitumor drug doxorubicin: Implications for the mechanisms of doxorubicin action and cytotoxicity. Mol. Pharmacol. 52, 658 (1997).
90. J. A. Bonner and V. Liengswangwong, Topoisomerase ii-independent doxorubicin-induced cytotoxicity in an extremely doxorubicin-resistant cell-line. Biochem. Biophys. Res. Commun. 198, 582 (1994).
91. Q.-Y. Cheng and B.-H. Han, Supramolecular hydrogel based on graphene oxides for controlled release system. J. Nanosci. Nanotechnol. 13, 755 (2013).
92. W. Zhang, Z. Y. Guo, D. Q. Huang, Z. M. Liu, X. Guo, and H. Q. Zhong, Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide. Biomaterials 32, 8555 (2011).
93. G. D. Liu, H. Shen, J. N. Mao, L. M. Zhang, Z. Jiang, T. Sun, Q. Lan. and Z. J. Zhang, Transferrin modified graphene oxide for glioma-targeted drug delivery: In vitro and in vivo evaluations. ACS Appl. Mater. Inter. 5, 6909 (2013).
94. H. W. Yang, Y. J. Lu, K. J. Lin, S. C. Hsu, C. Y. Huang, S. H. She, H. L. Liu, C. W. Lin, M. C. Xiao, S. P. Wey, P. Y. Chen, T. C. Yen, K. C. Wei, and C. C. M. Ma, EGRF conjugated PEGylated nanographene oxide for targeted chemotherapy and photothermal therapy. Biomaterials 34, 7204 (2013).
95. P. Breedveld, N. Zelcer, D. Pluim, O. Sonmezer, M. M. Tibben, J. H. Beijnen, A. H. Schinkel, O. van Tellingen, P. Borst, and J. H. M. Schellens, Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: Potential role for breast cancer resistance protein in clinical drug-drug interactions. Cancer Res. 64, 5804 (2004).
96. J. L. Marshall and R. J. Delap, Clinical pharmacokinetics and pharmacology of trimetrexate. Clin. Pharmacokinet. 26, 190 (1994).
97. M. Wojtoniszak, K. Urbas, M. Peruzynska, M. Kurzawski, M. Drozdzik, and E. Mijowska, Covalent drug conjugation of graphene oxide with methotrexate and its antitumor activity. Chem. Phys. Lett. 568, 151 (2013).
98. L. M. Zhang, J. G. Xia, Q. H. Zhao, L. W. Liu, and Z. J. Zhang, Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small 6, 537 (2010).
99. X. T. Zheng, P. Chen, and C. M. Li, Anticancer efficacy and subcellular site of action investigated by real-time monitoring of cellular responses to localized drug delivery in single cells. Small 8, 2670 (2012).
100. L. Du, S. Suo, D. Luo, H. Jia, Y. Sha, and Y. Liu, Hydroxyethylated graphene oxide as potential carriers for methotrexate delivery. J. Nanopart. Res. 15, 1708 (2013).
101. J. An, Y. Q. Gou, C. X. Yang, F. D. Hu, and C. M. Wang, Synthesis of a biocompatible gelatin functionalized graphene nanosheets and its application for drug delivery. Mat. Sci. Eng. C-Mater. 33, 2827 (2013).
102. R. Jin, X. Ji, Y. Yang, H. Wang, and A. Cao, Self-assembled graphene-dextran nanohybrid for killing drug-resistant cancer cells. ACS Appl. Mater. Inter. 5, 7181 (2013).
103. C. Wang, J. Mallela, U. S. Garapati, S. Ravi, V. Chinnasamy, Y. Girard, M. Howell, and S. Mohapatra, A chitosan-modified graphene nanogel for noninvasive controlled drug release. Nanomed.-Nanotechnol. 9, 903 (2013).
104. W. Miao, G. Shim, C. M. Kang, S. Lee, Y. S. Choe, H.-G. Choi, and Y.-K. Oh, Cholesteryl hyaluronic acid-coated, reduced graphene oxide nanosheets for anti-cancer drug delivery. Biomaterials 34, 9638 (2013).
105. K. P. Liu, J. J. Zhang, F. F. Cheng, T. T. Zheng, C. M. Wang, and J. J. Zhu, Green and facile synthesis of highly biocompatible graphene nanosheets and its application for cellular imaging and drug delivery. J. Mater. Chem. 21, 12034 (2011).
106. H. Kim, D. Lee, J. Kim, T.-I. Kim, and W. J. Kim, Photothermally Triggered cytosolic drug delivery via endosome disruption using a functionalized reduced graphene oxide. ACS Nano 7, 6735 (2013).
107. Y. Wang, K. Y. Wang, J. F. Zhao, X. G. Liu, J. Bu, X. Y. Yan, and R. Q. Huang, Multifunctional mesoporous silica-coated graphene nanosheet used for chemo-photothermal synergistic targeted therapy of glioma. J. Am. Chem. Soc. 135, 4799 (2013).
108. T. Kavitha, S. I. H. Abdi, and S. Y. Park, pH-Sensitive nanocargo based on smart polymer functionalized graphene oxide for sitespecific drug delivery. Phys. Chem. Chem. Phys. 15, 5176 (2013).
109. H. Q. Bao, Y. Z. Pan, Y. Ping, N. G. Sahoo, T. F. Wu, L. Li, J. Li, and L. H. Gan, Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery. Small 7, 1569 (2011).
110. U. Dembereldorj, M. Kim, S. Kim, E. O. Ganbold, S. Y. Lee, and S. W. Joe, A spatiotemporal anticancer drug release platform of PEGylated graphene oxide triggered by glutathione in vitro and in vivo. J. Mater. Chem. 22, 23845 (2012).
111. C. W. Liu, F. Xiong, H. Z. Jia, X. L. Wang, H. Cheng, Y. H. Sun, X. Z. Zhang, R. X. Zhuo, and J. Feng, Graphene-based anticancer nanosystem and its biosafety evaluation using a zebrafish model. Biomacromolecules 14, 358 (2013).
112. X. X. Ma, H. Q. Tao, K. Yang, L. Z. Feng, L. Cheng, X. Z. Shi, Y. G. Li, L. Guo, and Z. Liu, A functionalized graphene oxideiron oxide nanocomposite for magnetically targeted drug delivery, photothermal therapy, and magnetic resonance imaging. Nano Res. 5, 199 (2012).
113. U. Dembereldorj, M. Kim, S. Kim, E. O. Ganbold, S. Y. Lee, and S. W. Joe, A spatiotemporal anticancer drug release platform of PEGylated graphene oxide triggered by glutathione in vitro and in vivo. J. Mater. Chem. 22, 23845 (2012).
114. J. Gao, F. Bao, L. L. Feng, K. Y. Shen, Q. D. Zhu, D. F. Wang, T. Chen, R. Ma, and C. J. Yan, Functionalized graphene oxide modified polysebacic anhydride as drug carrier for levofloxacin controlled release. RSC Adv. 1, 1737 (2011).
115. J. Y. Liu, S. J. Guo, L. Han, T. S. Wang, W. Hong, Y. Q. Liu, and E. K. Wang, Synthesis of phospholipid monolayer membrane functionalized graphene for drug delivery. J. Mater. Chem. 22, 20634 (2012).
116. S. K. Misra, P. Kondaiah, S. Bhattacharya, and C. N. R. Rao, Graphene as a nanocarrier for tamoxifen induces apoptosis in transformed cancer cell lines of different origins. Small 8, 131 (2012).
117. X. C. Qin, Z. Y. Guo, Z. M. Liu, W. Zhang, M. M. Wan, and B. W. Yang, Folic acid-conjugated graphene oxide for cancer targeted chemo-photothermal therapy. J. Photochem. Photobiol. B 120, 156 (2013).
118. V. K. Rana, M. C. Choi, J. Y. Kong, G. Y. Kim, M. J. Kim, S. H. Kim, S. Mishra, R. P. Singh, and C. S. Ha, Synthesis and drug-delivery behavior of chitosan-functionalized graphene oxide hybrid nanosheets. Macromol. Mater. Eng. 296, 131 (2011).
119. G. S. Wang, G. Y. Chen, Z. Y. Wei, X. F. Dong, and M. Qi, Multifunctional Fe3O4/graphene oxide nanocomposites for magnetic resonance imaging and drug delivery. Mater. Chem. Phys. 141, 997 (2013).
120. G. C. Wei, M. M. Yan, R. H. Dong, D. Wang, X. Z. Zhou, J. F. Chen, and J. C. Hao, Covalent modification of reduced graphene oxide by means of diazonium chemistry and use as a drug-delivery system. Chem.-Eur. J. 18, 14708 (2012).
121. H. Kim, R. Namgung, K. Singha, I. K. Oh, and W. J. Kim, Graphene oxide-polyethylenimine nanoconstruct as a gene delivery vector and bioimaging tool. Bioconjugate Chem. 22, 2558 (2011).
122. Y. Yang, Y. M. Zhang, Y. Chen, D. Zhao, J. T. Chen, and Y. Liu, Construction of a graphene oxide based noncovalent multiple nanosupramolecular assembly as a scaffold for drug delivery. Chem.-Eur. J. 18, 4208 (2012).
123. X. T. Zheng and C. M. Li, Restoring basal planes of graphene oxides for highly efficient loading and delivery of beta-lapachone. Mol. Pharm. 9, 615 (2012).
124. X. J. Fan, G. Z. Jiao, W. Zhao, P. F. Jin, and X. Li, Magnetic Fe3O4-graphene composites as targeted drug nanocarriers for pH-activated release. Nanoscale 5, 1143 (2013).
125. X. Y. Yang, Y. S. Wang, X. Huang, Y. F. Ma, Y. Huang, R. C. Yang, H. Q. Duan, and Y. S. Chen, Multi-functionalized graphene oxide based anticancer drug-carrier with dual-targeting function and pH-sensitivity. J. Mater. Chem. 21, 3448 (2011).
126. C. Y. Wang, S. Ravi, U. S. Garapati, M. Das, M. Howell, J. Mallela, S. Alwarappan, S. S. Mohapatra, and S. Mohapatra, Multifunctional chitosan magnetic-graphene (CMG) nanoparticles: A theranostic platform for tumor-targeted co-delivery of drugs, genes and MRI contrast agents. J. Mater. Chem. B 1, 4396 (2013).
127. N. G. Sahoo, H. Q. Bao, Y. Z. Pan, M. Pal, M. Kakran, H. K. F. Cheng, L. Li, and L. P. Tan, Functionalized carbon nanomaterials as nanocarriers for loading and delivery of a poorly water-soluble anticancer drug: A comparative study. Chem. Commun. 47, 5235 (2011).
128. J. H. Byeon and Y. W. Kim, Continuous gas-phase synthesis of graphene nanoflakes hybridized by gold nanocrystals for efficient water purification and gene transfection. Chem. Eng. J. 229, 540 (2013).
129. L. Z. Feng, X. Z. Yang, X. Z. Shi, X. F. Tan, R. Peng, J. Wang, and Z. Liu, Polyethylene glycol and polyethylenimine dual-functionalized nano-graphene oxide for photothermally enhanced gene delivery. Small 9, 1989 (2013).
130. D. Yin, Y. Li, H. Lin, B. F. Guo, Y. W. Du, X. Li, H. J. Jia, X. J. Zhao, J. Tang, and L. Zhang, Functional graphene oxide as a plasmid-based Stat3 siRNA carrier inhibits mouse malignant melanoma growth in vivo. Nanotechnology 24, 105102 (2013).
131. B. A. Chen, M. Liu, L. M. Zhang, J. Huang, J. L. Yao, and Z. J. Zhang, Polyethylenimine-functionalized graphene oxide as an efficient gene delivery vector. J. Mater. Chem. 21, 7736 (2011).
132. L. Z. Feng, S. A. Zhang, and Z. A. Liu, Graphene based gene transfection. Nanoscale 3, 1252 (2011).
133. X. Zhou, F. Laroche, G. E. M. Lamers, V. Torraca, P. Voskamp, T. Lu, F. Q. Chu, H. P. Spaink, J. P. Abrahams, and Z. F. Liu, Ultrasmall graphene oxide functionalized with polyethylenimine (PEI) for very efficient gene delivery in cell and zebrafish embryos. Nano Res. 5, 703 (2012).
134. F. F. Cheng, W. Chen, L. H. Hu, G. Chen, H. T. Miao, C. Z. Li, and J. J. Zhu, Highly dispersible PEGylated graphene/Au composites as gene delivery vector and potential cancer therapeutic agent. J. Mater. Chem. B 1, 4956 (2013).
135. S. Kim, S. R. Ryoo, H. K. Na, Y. K. Kim, B. S. Choi, Y. Lee, D. E. Kim, and D. H. Min, Deoxyribozyme-loaded nano-graphene oxide for simultaneous sensing and silencing of the hepatitis C virus gene in liver cells. Chem. Commun. 49, 8241 (2013).
136. L. M. Zhang, Z. L. Wang, Z. X. Lu, H. Shen, J. Huang, Q. H. Zhao, M. Liu, N. Y. He, and Z. J. Zhang, PEGylated reduced graphene oxide as a superior ssRNA delivery system. J. Mater. Chem. B 1, 749 (2013).
137. F. Zhi, H. F. Dong, X. F. Jia, W. J. Guo, H. T. Lu, Y. L. Yang, H. X. Ju, X. J. Zhang, and Y. Q. Hu, Functionalized graphene oxide mediated adriamycin delivery and mir-21 gene silencing to overcome tumor multidrug resistance in vitro. PLoS ONE 8, e60034 (2013).
138. L. Zhou, W. Wang, J. Tang, J. H. Zhou, H. J. Jiang, and J. Shen, Graphene oxide noncovalent photosensitizer and its anticancer activity in vitro. Chem.-Eur. J. 17, 12084 (2011).
139. L. Zhou, H. J. Jiang, S. H. Wei, X. F. Ge, J. H. Zhou, and J. Shen, High-efficiency loading of hypocrellin B on graphene oxide for photodynamic therapy. Carbon 50, 5594 (2012).
140. F. Li, S. Park, D. Ling, W. Park, J. Y. Han, K. Na, and K. Char, Hyaluronic acid-conjugated graphene oxide/photosensitizer nanohybrids for cancer targeted photodynamic therapy. J. Mater. Chem. B 1, 1678 (2013).
141. Z. Hu, Y. D. Huang, S. F. Sun, W. C. Guan, Y. H. Yao, P. Y. Tang, and C. Y. Li, Visible light driven photodynamic anticancer activity of graphene oxide/TiO2 hybrid. Carbon 50, 994 (2012).
142. Z. Hu, J. Li, C. Y. Li, S. J. Zhao, N. Li, Y. F. Wang, F. Wei, L. Chen, and Y. D. Huang, Folic acid-conjugated graphene-ZnO nanohybrid for targeting photodynamic therapy under visible light irradiation. J. Mater. Chem. B 1, 5003 (2013).
143. B. Tian, C. Wang, S. Zhang, L. Z. Feng, and Z. Liu, Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide. ACS Nano 5, 7000 (2011).
144. P. Huang, C. Xu, J. Lin, C. Wang, X. S. Wang, C. L. Zhang, X. J. Zhou, S. W. Guo, and D. X. Cui, Folic acid-conjugated graphene oxide loaded with photosensitizers for targeting photodynamic therapy. Theranostics 1, 240 (2011).
145. Y. Cho and Y. Choi, Graphene oxide-photosensitizer conjugate as a redox-responsive theranostic agent. Chem. Commun. 48, 9912 (2012).
146. Y. Cho, H. Kim, and Y. Choi, A graphene oxide-photosensitizer complex as an enzyme-activatable theranostic agent. Chem. Commun. 49, 1202 (2013).
147. W. Miao, G. Shim, S. Lee, S. Lee, Y. S. Choe, and Y. K. Oh, Safety and tumor tissue accumulation of pegylated graphene oxide nanosheets for co-delivery of anticancer drug and photosensitizer. Biomaterials 34, 3402 (2013).
148. C. Falciani, A. Accardo, J. Brunetti, D. Tesauro, B. Lelli, A. Pini, L. Bracci, and G. Morelli, Target-selective drug delivery through liposomes labeled with oligobranched neurotensin peptides. Chemmedchem 6, 678 (2011).
149. N. Svensen, J. G. A. Walton, and M. Bradley, Peptides for cellselective drug delivery. Trends Pharmacol. Sci. 33, 186 (2012).
150. Y. X. Zhu, L. Che, H. M. He, Y. Jia, J. X. Zhang, and X. H. Li, Highly efficient nanomedicines assembled via polymer-drug multiple interactions: Tissue-selective delivery carriers. J. Control Release 152, 317 (2011).
151. A. Tsuji, Tissue selective drug delivery utilizing carrier-mediated transport systems. J. Control Release 62, 239 (1999).
152. N. X. Zhao, J. You, Z. H. Zeng, C. Li, and Y. L. Zu, An ultra ph-sensitive and aptamer-equipped nanoscale drug-delivery system for selective killing of tumor cells. Small 9, 3477 (2013).
153. X. J. Cai, C. Y. Dong, H. Q. Dong, G. M. Wang, G. M. Pauletti, X. J. Pan, H. Y. Wen, I. Mehl, Y. Y. Li, and D. L. Shi, Effective gene delivery using stimulus-responsive catiomer designed with redox-sensitive disulfide and acid-labile imine linkers. Biomacromolecules 13, 1024 (2012).
154. Y. Y. Li, X. Z. Zhang, H. Cheng, G. C. Kim, S. X. Cheng, and R. X. Zhuo, Novel stimuli-responsive micelle self-assembled from Y-shaped P(UA-Y-NIPAAm) copolymer for drug delivery. Biomacromolecules 7, 2956 (2006).
155. H. Wei, S. X. Cheng, X. Z. Zhang, and R. X. Zhuo, Thermo-sensitive polymeric micelles based on poly(N-isopropylacrylamide) as drug carriers. Prog. Polym. Sci. 34, 893 (2009).
156. C. W. Su, S. Y. Chen, and D. M. Liu, Polysaccharide-lecithin reverse micelles with enzyme-degradable triglyceride shell for overcoming tumor multidrug resistance. Chem. Commun. 49, 3772 (2013).
157. T. B. Ren, W. Wu, M. H. Jia, H. Q. Dong, Y. Y. Li, and Z. L. Ou, Reduction-cleavable polymeric vesicles with efficient glutathione-mediated drug release behavior for reversing drug resistance. ACS Appl. Mater. Inter. 5, 10721 (2013).
158. H. Q. Dong, C. Y. Dong, Y. Feng, T. B. Ren, Z. H. Zhang, L. Li, and Y. Y. Li, Engineering of peglayted camptothecin into core-shell nanomicelles for improving solubility, stability and combination delivery. Medchemcomm 3, 1555 (2012).
159. H. Y. Wen, H. Q. Dong, W. J. Xie, Y. Y. Li, K. Wang, G. M. Pauletti, and D. L. Shi, Rapidly disassembling nanomicelles with disulfide-linked PEG shells for glutathione-mediated intracellular drug delivery. Chem. Commun. 47, 3550 (2011).
160. Y. Kato, S. Ozawa, C. Miyamoto, Y. Maehata, A. Suzuki, T. Maeda, and Y. Baba, Acidic extracellular microenvironment and cancer. Cancer Cell Int. 13 (2013).
161. H. Q. Hu, J. H. Yu, Y. Y. Li, J. Zhao, and H. Q. Dong, Engineering of a novel pluronic F127/graphene nanohybrid for pH responsive drug delivery. J. Biomed. Mater. Res. A 100A, 141 (2012).
162. S. M. Zhu, J. B. Li, Y. H. Chen, Z. X. Chen, C. X. Chen, Y. Li, Z. W. Cui, and D. Zhang, Grafting of graphene oxide with stimuli-responsive polymers by using ATRP for drug release. J. Nanopart. Res. 14, 1132 (2012).
163. A. Al-Nahain, S. Y. Lee, I. In, K. D. Lee, and S. Y. Park, Triggered pH/redox responsive release of doxorubicin from prepared highly stable graphene with thiol grafted Pluronic. Int. J. Pharm. 450, 208 (2013).
164. X. J. Yang, X. Liu, Z. Liu, F. Pu, J. S. Ren, and X. G. Qu, Near-infrared light-triggered, targeted drug delivery to cancer cells by aptamer gated nanovehicles. Adv. Mater. 24, 2890 (2012).
165. C. P. McCoy, S. M. McGlinchey, C. R. Edwards, C. Brady, N. McGoldrick, L. Donnelly, C. Parsons, and J. F. Cowley, Triggered drug delivery from
166. Y. J. Jing, Y. H. Zhu, X. L. Yang, J. H. Shen, and C. Z. Li, Ultrasound-triggered smart drug release from multifunctional core-shell capsules one-step fabricated by coaxial electrospray method. Langmuir 27, 1175 (2011).
167. J. T. Robinson, S. M. Tabakman, Y. Y. Liang, H. L. Wang, H. S. Casalongue, D. Vinh, and H. J. Dai, Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy. J. Am. Chem. Soc. 133, 6825 (2011).
168. Z. M. Markovic, L. M. Harhaji-Trajkovic, B. M. Todorovic-Markovic, D. P. Kepic, K. M. Arsikin, S. P. Jovanovic, A. C. Pantovic, M. D. Dramicanin, and V. S. Trajkovic, In vitro comparison of the photothermal anticancer activity of graphene nanoparticles and carbon nanotubes. Biomaterials 32, 1121 (2011).
169. R. Kurapati and A. M. Raichur, Near-infrared light-responsive graphene oxide composite multilayer capsules: A novel route for remote controlled drug delivery. Chem. Commun. 49, 734 (2013).
170. A. Aied, U. Greiser, A. Pandit, and W. X. Wang, Polymer gene delivery: Overcoming the obstacles. Drug Discov. Today 18, 1090 (2013).
171. L. Drasar and M. Ledvina, Gene therapy: Cationic lipids for construction of nonviral vectors of nucleic acids. Chem. Listy 106, 646 (2012).
172. Z. P. Parra-Guillen, G. Gonzalez-Aseguinolaza, P. Berraondo, and I. F. Troconiz, Gene therapy: A pharmacokinetic/pharmacodynamic modelling overview. Pharm. Res. 27, 1487 (2010).
173. S. Patnaik and K. C. Gupta, Novel polyethylenimine-derived nanoparticles for in vivo gene delivery. Expert Opin. Drug Deliv. 10, 215 (2013).
174. Y. Gao, X. L. Liu, and X. R. Li, Research progress on siRNA delivery with nonviral carriers. Int. J. Nanomed. 6, 1017 (2011).
175. W. T. Godbey, K. K. Wu, and A. G. Mikos, Poly(ethylenimine) and its role in gene delivery. J. Control Release 60, 149 (1999).
176. C. Xu, D. R. Yang, L. Mei, B. G. Lu, L. B. Chen, Q. H. Li, H. Z. Zhu, and T. H. Wang, Encapsulating gold nanoparticles or nanorods in graphene oxide shells as a novel gene vector. ACS Appl. Mater. Inter. 5, 2715 (2013).
177. J. Zhang, L. Z. Feng, X. F. Tan, X. Z. Shi, L. G. Xu, Z. Liu, and R. Peng, Dual-polymer-functionalized nanoscale graphene oxide as a highly effective gene transfection agent for insect cells with cell-type-dependent cellular uptake mechanisms. Part. Part. Syst. Char. 30, 794 (2013).
178. Y. Y. Li, S. H. Hua, W. Xiao, H. Y. Wang, X. H. Luo, C. Li, S. X. Cheng, X. Z. Zhang, and R. X. Zhuo, Dual-vectors of anti-cancer drugs and genes based on pH-sensitive micelles self-assembled from hybrid polypeptide copolymers. J. Mater. Chem. 21, 3100 (2011).
179. P. Parhi, C. Mohanty, and S. K. Sahoo, Nanotechnology-based combinational drug delivery: An emerging approach for cancer therapy. Drug Discov. Today 17, 1044 (2012).
180. H. Q. Bao, Y. Z. Pan, Y. Ping, N. G. Sahoo, T. F. Wu, L. Li, J. Li, and L. H. Gan, Drug and gene chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery. Small 7, 1569 (2011).
181. H. J. Yoon and W. D. Jang, Nanotechnology-based photodynamic therapy. J. Porphyr. Phthalocya. 17, 16 (2013).
182. R. R. Allison, H. C. Mota, V. S. Bagnato, and C. H. Sibata, Bionanotechnology and photodynamic therapy - State of the art review. Photodiagn. Photodyn. 5, 19 (2008).
183. R. Ideta, F. Tasaka, W. D. Jang, N. Nishiyama, G. D. Zhang, A. Harada, Y. Yanagi, Y. Tamaki, T. Aida, and K. Kataoka, Nanotechnology-based photodynamic therapy for neovascular disease using a supramolecular nanocarrier loaded with a dendritic photosensitizer. Nano Lett. 5, 2426 (2005).
184. C. A. Robertson, D. H. Evans, and H. Abrahamse, Photodynamic therapy (PDT): A short review on cellular mechanisms and cancer research applications for PDT. J. Photoch. Photobio. B. 96, 1 (2009).
185. Z. Huang, H. P. Xu, A. D. Meyers, A. I. Musani, L. W. Wang, R. Tagg, A. B. Barqawi, and Y. K. Chen, Photodynamic therapy for treatment of solid tumors - Potential and technical challenges. Technol. Cancer Res. Treat. 7, 309 (2008).
186. Z. Huang, L. B. Li, H. W. Wang, X. L. Wang, K. H. Yuan, A. Meyers, L. H. Yang, and F. W. Hetzel, Photodynamic therapy - An update on clinical applications. J. Innov. Opt. Heal. Sci. 2, 73 (2009).
187. C. F. van Nostrum, Polymeric micelles to deliver photosensitizers for photodynamic therapy. Adv. Drug Deliver. Rev. 56, 9 (2004).
188. A. S. L. Derycke and P. A. M. de Witte, Liposomes for photodynamic therapy. Adv. Drug Deliver. Rev. 56, 17 (2004).
189. A. Sahu, W. I. Choi, J. H. Lee, and G. Tae, Graphene oxide mediated delivery of methylene blue for combined photodynamic and photothermal therapy. Biomaterials 34, 6239 (2013).
190. M. Wojtoniszak, D. Roginska, B. Machalinski, M. Drozdzik, and E. Mijowska, Graphene oxide functionalized with methylene blue and its performance in singlet oxygen generation. Mater. Res. Bull. 48, 2636 (2013).
191. L. Martiradonna, Multifunctional graphene. Nat. Mater. 12, 688 (2013).
192. L. M. Chang, S. N. Chen, P. F. Jin, and X. Li, Synthesis of multifunctional fluorescent magnetic graphene oxide hybrid materials. J. Colloid Interf. Sci. 388, 9 (2012).
193. A. P. Pandey, K. P. Karande, M. P. More, S. G. Gattani, and P. K. Deshmukh, Graphene based nanomaterials: Diagnostic applications. J. Biomed. Nanotechnol. 10, 179 (2014).
194. K. Jiang, L. Ma, J.Wang, and W. Chen, Graphene oxide and reduced graphene oxide: Synthesis, photoluminescence, and biotechnological applications. Rev. Nanosci. Nanotech. 2, 171 (2013).
195. Y. Li, J. Liu, H. Dong, G. Liu, and H. Hu, Engineering of a pluronic F127 functionalized magnetite/graphene nanohybrid for chemophototherapy. Nanotechnology 25, 065602 (2014).
196. C. Y. Wang, S. Ravi, U. S. Garapati, M. Das, M. Howell, J. Mallela, S. Alwarappan, S. S. Mohapatra, and S. Mohapatra, Multifunctional chitosan magnetic-graphene (CMG) nanoparticles: A theranostic platform for tumor-targeted co-delivery of drugs, genes and MRI contrast agents. J. Mater. Chem. B 1, 4396 (2013).
197. X. Y. Yang, X. Y. Zhang, Y. F. Ma, Y. Huang, Y. S. Wang, and Y. S. Chen, Superparamagnetic graphene oxide-Fe3 O4 nanoparticles hybrid for controlled targeted drug carriers. J. Mater. Chem. 19, 2710 (2009).
198. X. J. Fan, G. Z. Jiao, L. Gao, P. F. Jin, and X. Li, The preparation and drug delivery of a graphene-carbon nanotube-Fe3O4 nanoparticle hybrid. J. Mater. Chem. B 1, 2658 (2013).
199. G. Wang, G. Chen, Z. Wei, X. Dong, and M. Qi, Multifunctional Fe3 O4 /graphene oxide nanocomposites for magnetic resonance imaging and drug delivery. Mater. Chem. Phys. 141, 997 (2013).
200. V. C. Sanchez, A. Jachak, R. H. Hurt, and A. B. Kane, Biological interactions of graphene-family nanomaterials: An interdisciplinary review. Chem. Res. Toxicol. 25, 15 (2012).
201. C. Wang, C. Wu, X. Zhou, T. Han, X. Xin, J. Wu, J. Zhang, and S. Guo, Enhancing cell nucleus accumulation and dna cleavage activity of anti-cancer drug via graphene quantum dots. Sci. Rep.-UK 3, 2852 (2013).
202. A. Wang, K. Pu, B. Dong, Y. Liu, L. Zhang, Z. Zhang, W. Duan, and Y. Zhu, Role of surface charge and oxidative stress in cytotoxicity and genotoxicity of graphene oxide towards human lung fibroblast cells. J. Appl. Toxicol. 33, 1156 (2013).
203. C. Bussy, H. Ali-Boucetta, and K. Kostarelos, Safety considerations for graphene: Lessons learnt from carbon nanotubes. Acc. Chem. Res. 46, 692 (2013).
204. L. Guo, A. Von Dem Bussche, M. Buechner, A. H. Yan, A. B. Kane, and R. H. Hurt, Adsorption of essential micronutrients by carbon nanotubes and the implications for nanotoxicity testing. Small 4, 721 (2008).
205. N. V. S. Vallabani, S. Mittal, R. K. Shukla, A. K. Pandey, S. R. Dhakate, R. Pasricha, and A. Dhawan, Toxicity of graphene in normal human lung cells (BEAS-2B). J. Biomed. Nanotechnol. 7, 106 (2011).
206. W. Z. Teo, E. L. K. Chng, Z. Sofer, and M. Pumera, Cytotoxicity of halogenated graphenes. Nanoscale 6, 1173 (2014).
207. C. Wu, C. Wang, T. Han, X. Zhou, S. Guo, and J. Zhang, Insight into the cellular internalization and cytotoxicity of graphene quantum dots. Adv. Healthc. Mater. 2, 1613 (2013).
208. W. D. Zhang, C. Wang, Z. J. Li, Z. Z. Lu, Y. Y. Li, J. J. Yin, Y. T. Zhou, X. F. Gao, Y. Fang, G. J. Nie, and Y. L. Zhao, Unraveling stress-induced toxicity properties of graphene oxide and the underlying mechanism. Adv. Mater. 24, 5391 (2012).
209. K. Yang, Y. J. Li, X. F. Tan, R. Peng, and Z. Liu, Behavior and toxicity of graphene and its functionalized derivatives in biological systems. Small 9, 1492 (2013).